Nexalin Technology (NXL) Consolidated Net Income (2021 - 2026)
Nexalin Technology's quarterly Consolidated Net Income came in at -$2.1 million in Q1 2026, down 5.51% year-on-year from -$2.2 million in Q1 2025, and up 11.77% quarter-over-quarter from -$2.4 million in Q4 2025.
Nexalin Technology has reported Consolidated Net Income for 6 years, with the latest figure at -$2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income fell 5.51% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at -$8.3 million (up 2.59% YoY), and the FY2025 full-year result was -$8.2 million, down 8.0% from the prior year.
- Consolidated Net Income for Q1 2026 stood at -$2.1 million, up from -$2.4 million in the prior quarter.
- The five-year high for Consolidated Net Income was -$303646.0 in Q3 2022, with the low at -$2.8 million in Q4 2024.
- Average Consolidated Net Income over 5 years is -$1.4 million, with a median of -$1.3 million recorded in 2024.
- Year-over-year, Consolidated Net Income soared 83.34% in 2022 and slumped 656.54% in 2023.
- Tracing NXL's Consolidated Net Income over 5 years: stood at -$733113.0 in 2022, then decreased by 6.49% to -$780669.0 in 2023, then plunged by 262.95% to -$2.8 million in 2024, then gained by 16.13% to -$2.4 million in 2025, then grew by 11.77% to -$2.1 million in 2026.
- The last three Consolidated Net Income figures came in at -$2.1 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | -2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10 Mn |
| Dec 31, 2025 | -2.38 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.99 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | -2.45 Mn |
| Jun 30, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.05 Mn |
| Dec 31, 2023 | -780,669.00 |
| Sep 30, 2023 | -2.30 Mn |
| Jun 30, 2023 | -822,437.00 |
| Mar 31, 2023 | -748,414.00 |
| Dec 31, 2022 | -733,113.00 |
| Sep 30, 2022 | -303,646.00 |
| Jun 30, 2022 | -445,103.00 |
| Mar 31, 2022 | -393,249.00 |
| Dec 31, 2021 | -595,928.00 |
| Sep 30, 2021 | -1.82 Mn |